You need to be logged in to view this video
The Biotech indices have bounced 30% in 30 days (June 16-July 16) as over-sold conditions and biotech/drugs being immune to economic/recession fears have attracted new fund flows.
John McCamant
Medical Technology Stock Letter,
Editor
John McCamant joined the leading investment newsletter, Medical Technology Stock Letter, as an associate editor in 1987 and was named editor in August 2000. He has spent over 35 years on the front lines of biotechnology investing. In his previous role as an equities analyst for the American Healthcare fund, Mr. McCamant uncovered investment opportunities and guided investment strategy.
Trending Now
Filter By Category
Filter By Keywords
Loading...